Share this article
Share this article
ResearchAndMarkets.com s offering.
Sepsis was killing over 30 million people a year with no definitive diagnostic in hand. And now the COVID-19 Pandemic has increased the sepsis death toll. The race is on using all the genomic and molecular diagnostic tools that have come to the fore in the last decade. It is not clear who will be the winner, but the stakes are global and large. Emergency life-saving diagnostics can command a premium in the market, especially deaths related to COVID-19 infections. Understand the different drivers of this huge global diagnostic market and where the opportunity lies.
Vizgen Launches With $14M Series A Financing
SeqWell Raises $9M in Series B Round
MGI Tech Introduces Portable Sequencer, Single-Cell Prep Device
Celsius Therapeutics to Use Single-Cell Platform in Immuno-Oncology
Genomics Expects $271M In Proceeds
Celsius Therapeutics, Janssen Biotech Form Biomarker Discovery Alliance
Bio-Rad, 10x Genomics Claim Single-Cell Patent Fight Victories on Different Fronts
Bio-Rad Launches its Single Cell scATAC-Seq Solution
Genomics Acquires Spatial Transcriptomics
Mission Bio Launches Tapestri for Targeted Single-Cell DNA Custom Panels
SingulOmics Detects Somatic Single Nucleotide Variations in Single Cells
1CELLBIO and OMI to validate Single Cell Analysis for Personalized Medicine
Sony MA900 Cell Sorter Nominated
4.2.3 Wellness Hurts
4.3 Diagnostic Technology Development179
4.3.2 NAT vs. Lateral Flow
4.3.3 The Unusual Role of GPS
4.3.4 Self and Send Competition
4.4.5 The Relationship to DTC Genetic
4.4.6 The Relationship to TeleHealth
4.4.7 Sample Collection - Who Knew?
5. OTC/DTC Infectious Disease Testing Recent Developments
Recent Developments - Importance and How to Use This Section
Importance of These Developments
FemtoDx Launches Rapid At-Home Test Development for COVID-19
FDA approves first at-home coronavirus test
Free Home HIV Tests Detect More Infections
Biohacking trend supports self testing.
PerkinElmer and EverlyWell to Expand U.S. At-Home Health Test Market
Mylan, Atomo Diagnostics Get WHO Prequalification Approval for HIV Self-Test
World Whole Genome and Exome Sequencing Markets, 2021-2025: COVID-19 Drives Overnight Global Growth in Pathogen Sequencing - A New Industry Emerges.
December 16, 2020 10:43 ET | Source: Research and Markets Research and Markets Dublin, IRELAND
ResearchAndMarkets.com s offering.
The COVID Pandemic has created a surge in Whole Genome Sequencing of Pathogens but cancer-related activity has suffered. Find out all about it in the comprehensive report of Whole Genome Sequencing. The complete genome of the COVID virus is included as an example of the work being done.
Will all newborns receive Whole Genome Sequencing at birth? How fast will Direct to Consumer Testing grow? What sequencing technology will take the lead? What s holding the industry back? Where are the over 800 locations that have high throughput devices?
4.2.3 Wellness Hurts
4.3 Diagnostic Technology Development
4.3.2 NAT vs. Lateral Flow
4.3.3 The Unusual Role of GPS
4.3.4 Self and Send Competition
4.4.5 The Relationship to DTC Genetic
4.4.6 The Relationship to TeleHealth
4.4.7 Sample Collection - Who Knew?
5. OTC/DTC Infectious Disease Testing Recent Developments
Recent Developments - Importance and How to Use This Section
Importance of These Developments
Biohacking trend supports self testing.
PerkinElmer and EverlyWell to Expand U.S. At-Home Health Test Market
Mylan, Atomo Diagnostics Get WHO Prequalification Approval for HIV Self-Test
Miraca Holdings Inc. and Seventh Sense Biosystems, Inc. Announce Distribution Agreement
OraSure Technologies, Inc. Announces Two Acquisitions
Mylan signs HIV test commercialisation deal with Atomo Diagnostics